SPHK1 and head and neck squamous cell carcinoma: The research demonstrated that GNR-SphK siRNA nanocomposite could efficiently deliver SphK siRNA to HNSCC cells and sensitize the tumor to radiation from a gamma cell 40 irradiation machine with 137Cs source.